Bafna Pharmaceuticals Limited reported earnings results for the fourth quarter ended March 31, 2024. For the fourth quarter, the company reported sales was INR 413.98 million compared to INR 422.44 million a year ago. Revenue was INR 419.13 million compared to INR 425.02 million a year ago.

Net income was INR 14.55 million compared to INR 53.72 million a year ago. Basic earnings per share from continuing operations was INR 0.62 compared to INR 2.27 a year ago. Diluted earnings per share from continuing operations was INR 0.62 compared to INR 2.27 a year ago.